Diane Caruana
Substitution, Not Abstinence: Danish Data Are The Latest to Teach us...
Throughout history, major advances in public health have rarely moved forward without opposition. From clean water systems to food safety laws, vaccinations, and air-quality...
Bias, Confusion and Consequences: How Misleading Vape Studies are Undermining Public...
Over the past decade, vaping has been one of the most significant public health breakthroughs in reducing smoking-related harm. Millions of smokers in the...
Snus vs Nicotine Pouches: Comparing the Safety and Science Behind The...
For decades, Sweden’s traditional tobacco pouch, snus, has stood apart from cigarettes as a safer nicotine alternative. In recent years, nicotine pouches, a modern,...
Proof and Prejudice: The Science Policymakers Are Ignoring About Vapes and...
These findings of course align with similar reviews by Public Health England (now the UK Office for Health Improvement and Disparities), Cancer Research UK,...
Why is the UK Turning Its Back on Its Own Successful...
For over a decade the UK was the global anchor example of evidence-based tobacco harm reduction. University academics, economists and THR advocates worldwide cited...
How Cultural Frames Shape Tobacco Harm Reduction (or Lack Of) in...
As numerous Asian countries move further towards restricting novel nicotine products, it becomes clearer that across Asia, the policy trend around products such as...
A Subtle But Vital Shift: The EU Softens Its Position On...
With COP11 now imminent in Geneva, a very unexpected development inside Brussels has shifted tone and energy across the European harm reduction world. After...
The Second Life of Juul: Why the Brand’s Return Matters for...
For the first time after being cast in the shadows, Juul Labs appears to be launching a strategic reset. The company — once valued...









